Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly A Metcalfe

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.
International Journal of Cancer|January 16, 2008
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersKelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, et al.
Cancer|December 26, 2022
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?Kelly A Metcalfe, Jacek Gronwald, Nadine M Tung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2014
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutationAmy P M Finch, Jan Lubinski, Pål Møller, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.
International Journal of Cancer|January 16, 2008
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersKelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, et al.
Cancer|December 26, 2022
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?Kelly A Metcalfe, Jacek Gronwald, Nadine M Tung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2014
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutationAmy P M Finch, Jan Lubinski, Pål Møller, et al.
Pageof 7